🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Elaprase (idursulfase), a large molecular protein, is not expected to cross...
Status
Completed
Location
University of North Carolina at Chapel Hill
Start Date
2009-11-18
Trial ID
NCT00920647
Treatments Being Tested
This is an open-label, single-arm, Phase II investigator-initiated trial of...
Status
Unknown
Location
The Second Affiliated Hospital of SchoowUniversity
Start Date
2023-04-01
Trial ID
NCT05790447
Treatments Being Tested
Background: Despite the introduction of highly effective antiretroviral th...
Status
Completed
Location
Oslo University Hospital, Ullevål
Start Date
2012-09
Trial ID
NCT01627678
Treatments Being Tested
This is a Multicenter, Double-Blind, Randomized, Comparative Efficacy and S...
Status
Completed
Location
Mylan Investigational Site 3502
Start Date
2015-03
Trial ID
NCT02467868
This study aims to evaluate the ability of G8, CARG, and Frailty scales to ...
Status
Active Not Recruiting
Location
Çanakkale Onsekiz Mart Univercity
Start Date
2025-01-02
Trial ID
NCT07151794
This is a two-part Phase 1/2 dose escalation and dose expansion study of an...
Status
Completed
Location
Research Facility
Start Date
2017-09-07
Trial ID
NCT02963831
Treatments Being Tested
Retinoblastoma is a childhood cancer which affects the retina of the eye. T...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2005-04-07
Trial ID
NCT00186888
The goal of this study is to uncover the molecular mechanisms responsible f...
Status
Recruiting
Location
Chungnam National University Hospital
Start Date
2025-12-01
Trial ID
NCT07481396
This phase I trial tests the effect of allogeneic Orca-Q stem cell transpla...
Status
Not Yet Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2026-09-01
Trial ID
NCT07759102
RATIONALE: Vaccines made from the HER2/neu antigen may make the body build ...
Status
Completed
Location
University of Washington School of Medicine
Start Date
1996-04
Trial ID
NCT00003002
Treatments Being Tested